v3.25.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK OPTION GRANTED

During the three months ended March 31, 2025 and 2024, the Company granted options to purchase the number of shares of the Company’s common stock set forth in the table below (in thousands):

 

   2025   2024 
   Three months ended March 31, 
   2025   2024 
Stock options granted   1,831    1,874 
SCHEDULE OF WEIGHTED-AVERAGE ASSUMPTIONS USED FOR STOCK OPTIONS GRANTED

The following weighted-average assumptions were used for stock options granted during the three months ended March 31, 2025 and 2024:

 

   2025   2024 
   Three months ended March 31, 
   2025   2024 
Weighted average risk-free rate   4.42%   4.49%
Weighted average volatility   116.69%   99.13%
Dividend yield   0.00%   0.00%
Expected term   5.98 years    6.08 years 
SCHEDULE OF WEIGHTED AVERAGE GRANT-DATE FAIR VALUE OF STOCK OPTIONS

The per-share weighted average grant-date fair value of stock options granted during the three months ended March 31, 2025 and 2024 were as follows:

 

   2025   2024 
   Three months ended March 31, 
   2025   2024 
Weighted average grant date fair value  $0.29   $1.45 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

For the three ended March 31, 2025 and 2024, the Company recognized stock-based compensation expense as follows (in thousands):

 

   2025   2024 
   Three months ended March 31, 
   2025   2024 
Research and development  $17   $46 
General and administrative   485    236 
Total  $502   $282